EMA gives positive opinion to BI hypertension drug

Tuesday 27 July 2010

The European Medicines Agency’s main scientific committee has recommended that Boehringer Ingelheim’s new combination pill for hypertension, Twynsta, be approved for marketing.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom